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inTRODUCTiOn
The human saphenous vein (HSV) remains the most common conduit for peripheral and aortocoro-
nary bypass operations in the United States (1, 2), with ever improving, though suboptimal long-term 
patency rates. The mishandling of vein grafts during explantation, preparation, and autotransplanta-
tion is gaining attention as a source of injury portending increased short-term thrombosis as well as 
acceleration of neointimal formation, the most common cause of vein graft failure from 2 months to 
2 years postoperatively (3, 4). The handling of vein grafts during the explantation has been thought-
fully addressed, as “no-touch” open harvest has emerged as an approach stressing a minimization 
of trauma to tissue handling. In “no-touch” harvesting, the graft is removed with a pedicle of sur-
rounding tissue. This has been shown to maintain structural and functional integrity of all cell layers, 
prevent spasm (5), and improve graft patency (6, 7), while conferring protection from subsequent 
intraoperative manipulations (8, 9).
Nonetheless, once HSV has been fully explanted, manipulations to the conduit are routinely 
performed to make the anastomosis technically simpler and safer. The most well-characterized and 
injurious of these intraoperative manipulations is intraluminal radial distension (10). HSV is rou-
tinely cannulated and distended using a handheld syringe to infuse a solution or autologous blood, 
which dilates the vein. This procedure serves to disrupt any valves, increase the luminal diameter, 
identify leaks or injuries, prevent spasm, and ultimately, facilitate an easier anastomosis (11, 12). It is 
the opinion of the authors that this practice should be done with great care, emphasizing minimiza-
tion of distension pressure using either controlled distension or a tool, such as a pressure release 
valve. While not conclusive, existing data strongly suggest that mitigation of distension-induced 
graft injury may prevent both early and delayed graft failure due to thrombosis and neointimal 
hyperplasia, respectively.
SUMMARY OF THE LiTERATURE
Starting in the late 1970s, the practice of unregulated intraluminal distension became the target of 
significant research (13, 14). Biochemical and biomechanical effects of intraoperative distension were 
progressively characterized throughout the next several decades. Unregulated distension of HSV 
graft can exert radial pressures as great as 600–700 mmHg, far in excess of physiologic systolic blood 
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pressure, which of itself is supraphysiologic to the unadapted 
venous wall (11, 13, 15, 16). There are myriad biochemical and 
biomechanical changes to the cells and extracellular matrix that 
occur in HSV conduit upon arterial implantation, with chronic 
exposure to an arterial distension pressure. However, there is a 
unique profile of biochemical and biomechanical changes that 
have been shown to occur with acute intraoperative distension, 
particularly involving the critical endothelial layer whose integ-
rity is most indispensable for graft patency.
Intraoperative distension exerts a brief unidirectional force 
similar to laminar shear stress on the conduit. The harmful 
biochemical and biomechanical effects induced are decidedly dif-
ferent from those observed in chronically arterialized endothelial 
cells (14). Chiefly, distension of HSV leads to significant and pres-
sure-dependent endothelial denudation. This was first reported 
in 1980, when scanning electron microscopy revealed qualita-
tively severe endothelial damage in monkey saphenous vein at 
700 mmHg distension, though normal morphology was observed 
at pressures of 300–400 mmHg (13). While several ensuing stud-
ies over the decade demonstrated a qualitative destruction of the 
endothelial monolayer, Angelini and colleagues first quantified 
this by using stimulated prostacyclin generation of vascular 
tissue as a surrogate for the presence of an endothelial cell. In 
their formative experiment, concentrations of prostacyclin were 
measured in fresh and surgically prepared HSV, both spontane-
ously and after vortex stimulation. Prostacyclin is an endothelial-
derived prostaglandin, which works synergistically with nitric 
oxide to prevent thrombosis (17, 18). Angelini et al.’s findings that 
vortex-stimulated prostacyclin generation increased in response 
to surgical preparation were expanded to determining that it was 
indeed the distension aspect of surgical preparation, particularly 
with pressures greater than 300  mmHg, that most contributed 
to impaired stimulated prostacyclin generation (19). Measuring 
stimulated prostacyclin as a surrogate marker, this allowed the 
reliable quantification of degree of de-endothelialization that 
would become essential in multiple future experiments (19).
Microscopic quantification of denudation has further been 
quantified in several modern reports. Chester and colleagues 
reported a significant decrement in staining for endothelial 
markers endothelial nitric oxide synthase (eNOS), platelet 
endothelial cell adhesion molecule (CD31), and von Willebrand 
Factor (vWF) in segments of HSV distended to 300  mmHg, 
though no changes were observed at 100  mmHg distension 
relative to non-distended control tissue (20). Also, 300 mmHg 
was a critical distension pressure for decreased expression of 
the endothelial marker CD34 on HSV (21, 22). Similar results 
have been reported demonstrating impaired endothelial staining 
after full surgical manipulation, though surgical skin marking or 
preservation in solution could contribute to these findings (12, 
23–26). Seminal work by Stigler and colleagues revealed sequen-
tially increasing HSV endothelial denudation from median loss 
of 29–54% to 75–91% at respective pressures of 50, 100, 150, 
and 300 mmHg, as determined by CD31 staining, though HSV 
grafts were exposed to the pressure continuously for 30 min (27). 
In a porcine model, unregulated distension of saphenous vein 
was recently been shown to cause significantly decreased eNOS 
and CD31 staining, changes fully mitigated by distension via an 
in-line pressure release valve that limits intraluminal pressure to 
a more physiologic 140 mmHg (11).
Functional assessment of vascular endothelium is easily quan-
tified using an organ bath. The apparatus allows for the suspen-
sion of vascular smooth muscle tissue on a force transducer (28). 
The addition of acetylcholine or a cholinomimetic to a submerged 
vascular ring can cause activation of eNOS with subsequent 
nitric oxide generation and release. Nitric oxide then causes a 
cGMP-mediated vascular smooth muscle relaxation, the degree 
of which can be quantified. Endothelial-dependent physiologic 
responses are a valuable surrogate for denudation; however, there 
are limitations to its interpretation. Endothelial responses may be 
decreased in part due of endothelial cells that are dysfunctional 
in their production and release of nitric oxide. Data suggesting a 
significant component of endothelial dysfunction were reported 
by Okon and colleagues in 2004; vWF staining on distended 
veins remained intense, despite loss of endothelial-dependent 
relaxation (29). Additionally, distension is known to cause mild 
smooth muscle necrosis, decreasing the graft’s responsiveness to 
endothelial-derived nitric oxide (30, 31).
Distension has shown the ability to upregulate markers of 
inflammation that are governed by the activation of nuclear 
factor-κB (NF-κB) and subsequent generation of the cytokine 
TNF-alpha (24, 32–34). HSV distended at 300  mmHg for 
2 min demonstrated an average of 33% endothelial denudation; 
however, significant upregulation of endothelial intercellular 
adhesion molecule (ICAM-1), vascular cell adhesion molecule 
(VCAM-1), and P-selectin was also observed (35). In addition to 
NF-κB activation, lack of nitric oxide generation may also con-
tribute to this change (35–37). Upregulation of these cell surface 
adhesion molecules promotes interactions with integrins on cir-
culating neutrophils, monocytes, and platelets with subsequent 
transmigration into the vessel wall, events known to be early steps 
in graft obstruction (35). P-selectin, in particular, is implicated 
in the promotion of platelet aggregation in regions of vascular 
injury, leading to thrombosis (38). Its downregulation in vascular 
endothelium represents an emerging approach in the treatment 
of vein graft failure (38). Additionally, increased vascular perme-
ability has been linked to ICAM-1 expression (33, 39).
These findings were replicated by Khaleel and colleagues in 
2012 (16). Additional endothelial markers of inflammation were 
also found to be upregulated as well, via immunostaining and 
real-time polymerase chain reaction analyses. Toll-like receptors 
TLR2 and TLR4 were both increased in distended HSV, in direct 
proportion to luminal distension pressures. The expression of 
these receptors too is enhanced by TNF-alpha and contributes to 
immune system activation in cases of pathogen-induced inflam-
mation (40). Their expression may accelerate vein graft failure 
as well. Recent data suggest that TLR2 expression may promote 
graft failure in vascular tissue and that this may be due to its 
promotion of medial smooth muscle cell migration, a key event 
in atherogenesis and neointimal formation (40–42). A marker 
of acute inflammation, endothelial TLR4 upregulation was also 
seen in distended HSV (16, 40). Its contribution to neointimal 
formation is well-established, as TLR4-deficient mice have shown 
not to develop a neointima (16). However, these consequences 
are primarily due to TLR4 upregulation on vascular smooth 
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muscle cells rather than endothelium (43). Furthermore, both 
endothelial TLR2 and TLR4 have been implicated in the binding 
of the β2-glycoprotein moiety on circulating inflammatory cells, 
promoting thrombosis (44, 45).
While penetration of circulating monocytes into the vascular 
medial layer represents one of the inciting events of atherogenesis, 
subendothelial migration with lipid accumulation and formation 
of foam cells directly follows (46). Distension leads to increased 
expression of endothelial scavenger receptors SR-A and SR-B 
(16). Largely found on macrophages, these receptors are also 
found in vascular smooth muscle cells and endothelium. Ligand 
binding to these receptors amplified its expression and generates 
a positive feedback loop. Consequences of distension-induced 
expression and ligand binding include lipid peroxidation, 
endothelial dysfunction, apoptosis, and most concerningly, foam 
cell formation.
COnCLUSiOn
While only a few key offenders are summarized herein, there 
are a host of other adhesion molecules, toll-like receptors, and 
scavenger receptors that are ostensibly overexpressed in distended 
HSV, particularly those that are also regulated by NF-κB translo-
cation (24). Many of these changes likely contribute to vein graft 
failure. There are no studies in human patients examining the 
influence of vein graft distension pressure on patency; however, 
in the authors’ opinion, minimization of distension represents a 
simple modification to the conduit preparation process that may 
very well prevent graft failure, the extent to which, however, is 
unclear. Options exist to minimize distension, however, including 
pressure-regulated syringes or pressure release valves to prevent 
undue pressurization of the saphenous vein grafts (25, 26). These 
represent simple modifications to the vein graft preparation 
process that preserve functional and structural properties of the 
conduit endothelium, and thus, may very plausibly abrogate or 
retard thrombosis and neointimal hyperplasia.
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